Literature DB >> 2055248

Evidence that CCKB receptors mediate the regulation of exploratory behaviour in the rat.

J Harro1, E Vasar.   

Abstract

Peripheral administration of cholecystokinin tetrapeptide (CCK-4) at non-sedative doses (25-50 micrograms/kg) decreased the exploratory activity of rats in an elevated plus-maze. This effect was antagonized by treatment with CCK receptor antagonists proglumide (1 and 10 mg/kg), lorglumide (0.1 and 1 mg/kg), L 365,260 (10 micrograms/kg) and devazepide (1 mg/kg). The results suggest that the exploratory behaviour of rats can be altered by pharmacological manipulations at CCK-B receptors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2055248     DOI: 10.1016/0014-2999(91)90156-k

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  16 in total

1.  Wiring and volume transmission in rat amygdala. Implications for fear and anxiety.

Authors:  Miguel Pérez de la Mora; Kirsten X Jacobsen; Minerva Crespo-Ramírez; Candy Flores-Gracia; Kjell Fuxe
Journal:  Neurochem Res       Date:  2008-05-13       Impact factor: 3.996

2.  CCK-A and CCK-B selective receptor agonists and antagonists modulate olfactory recognition in male rats.

Authors:  M Lemaire; G A Böhme; O Piot; B P Roques; J C Blanchard
Journal:  Psychopharmacology (Berl)       Date:  1994-08       Impact factor: 4.530

3.  Antidepressant-like effects of CCKB antagonists in mice: antagonism by naltrindole.

Authors:  M Derrien; C Durieux; B P Roques
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

4.  Targeted mutation of CCK2 receptor gene modifies the behavioural effects of diazepam in female mice.

Authors:  Sirli Raud; Kertu Rünkorg; Alar Veraksits; Ain Reimets; Aleksei Nelovkov; Urho Abramov; Toshimitsu Matsui; Michel Bourin; Vallo Volke; Sulev Kõks; Eero Vasar
Journal:  Psychopharmacology (Berl)       Date:  2003-04-23       Impact factor: 4.530

5.  The benzodiazepine antagonist flumazenil blocks the effects of CCK receptor agonists and antagonists in the elevated plus-maze.

Authors:  P Chopin; M Briley
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Social isolation of rats increases the density of cholecystokinin receptors in the frontal cortex and abolishes the anti-exploratory effect of caerulein.

Authors:  E Vasar; E Peuranen; J Harro; A Lang; L Oreland; P T Männistö
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-07       Impact factor: 3.000

7.  Cholecystokinin and psychiatric disorders : role in aetiology and potential of receptor antagonists in therapy.

Authors:  J Shlik; E Vasar; J Bradwejn
Journal:  CNS Drugs       Date:  1997-08       Impact factor: 5.749

8.  Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients.

Authors:  H J van Megen; H G Westenberg; J A den Boer; J R Haigh; M Traub
Journal:  Psychopharmacology (Berl)       Date:  1994-04       Impact factor: 4.530

9.  Modelling anxiety in humans for drug development.

Authors:  Martin Siepmann; Peter Joraschky
Journal:  Curr Neuropharmacol       Date:  2007-03       Impact factor: 7.363

10.  The CCK-system underpins novelty-seeking behavior in the rat: gene expression and pharmacological analyses.

Authors:  Santiago J Ballaz; Huda Akil; Stanley J Watson
Journal:  Neuropeptides       Date:  2008-04-14       Impact factor: 3.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.